| URL | Priority | Change frequency | Last modified (GMT) |
|---|---|---|---|
| https://alzheon.com/clinical-benefits-tramiprosate-alzheimers-disease-associated-higher-number-apoe4-alleles-apoe4-gene-dose-effect/ | 60% | Monthly | 2019-09-23 16:10 |
| https://alzheon.com/gene-dose-effect-alzheons-alz-801-drug-targeting-alzheimers-disease/ | 60% | Monthly | 2019-09-23 16:10 |
| https://alzheon.com/alzheon-publishes-new-analyses-from-phase-3-studies-showing-clinical-benefit-of-tramiprosate-in-alzheimers-patients-who-are-carriers-of-apoe4-the-major-genetic-risk-factor-in-up-to-65-percen/ | 60% | Monthly | 2019-09-23 16:10 |
| https://alzheon.com/little-known-drug-company-answer-alzheimers-patients/ | 60% | Monthly | 2019-09-23 16:10 |